data_1kef_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kef _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.343 -0.244 . . . . 7.1100000000000003 110.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -126.28 128.02 46.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.317 -1.364 . . . . 5.3899999999999997 107.317 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -116.14 88.74 2.95 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.998 -1.482 . . . . 5.7400000000000002 106.998 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.52 115.81 16.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.062 0.545 . . . . 5.4699999999999998 109.911 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.7 mt -112.1 92.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 104.935 -2.246 . . . . 4.1900000000000004 104.935 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.2 m -77.93 107.21 10.3 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.184 0.992 . . . . 5.46 108.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 mt -108.62 175.56 5.42 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 113.662 -1.608 . . . . 4.3200000000000003 107.719 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.86 179.64 4.17 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 122.754 1.264 . . . . 6.6600000000000001 111.097 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.51 -46.35 88.83 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 116.955 -1.498 . . . . 9.3100000000000005 113.29 163.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.54 -89.21 0.36 Allowed Glycine 0 CA--C 1.544 1.867 0 CA-C-N 119.346 0.976 . . . . 7.5099999999999998 113.876 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.78 161.53 23.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.944 1.298 . . . . 9.25 108.779 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.314 1.3 t 70.21 -139.58 0.06 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.58 -1.325 . . . . 6.2000000000000002 112.69 169.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.62 -96.89 0.09 OUTLIER Glycine 0 N--CA 1.482 1.707 0 CA-C-N 119.509 1.049 . . . . 5.2000000000000002 112.28 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.55 -72.19 0.7 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.35 -0.833 . . . . 4.5499999999999998 109.198 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.88 -63.05 0.39 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 109.726 -1.35 . . . . 2.2200000000000002 109.726 -164.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -90.22 146.86 23.93 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.249 1.02 . . . . 3.25 112.404 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.19 125.1 28.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.295 -1.321 . . . . 2.8100000000000001 109.281 167.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 pt -101.89 149.98 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.346 1.058 . . . . 2.98 109.875 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.41 124.0 37.09 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.75 -1.114 . . . . 4.1600000000000001 109.797 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.63 168.48 54.8 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 122.005 0.78 . . . . 4.6500000000000004 113.489 165.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.14 -61.77 0.02 OUTLIER Glycine 0 CA--C 1.536 1.395 0 CA-C-N 114.368 -0.916 . . . . 5.3099999999999996 113.899 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -61.53 -24.79 66.86 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.287 1.958 . . . . 5.9400000000000004 116.287 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -123.65 -53.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.966 1.306 . . . . 6.75 110.681 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -116.58 88.36 24.18 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.217 -1.373 . . . . 6.7000000000000002 108.92 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.31 90.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.756 2.971 . . . . 7.5300000000000002 115.441 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -42.7 77.92 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.177 -0.919 . . . . 5.79 113.057 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.3 mm -92.08 146.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 108.516 -0.92 . . . . 6.4000000000000004 108.516 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.31 76.22 0.44 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-N 115.588 -0.733 . . . . 7.3799999999999999 112.402 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.97 -62.24 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 118.836 -0.602 . . . . 7.8600000000000003 110.71 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.81 164.11 29.49 Favored Pre-proline 0 CA--C 1.572 1.802 0 C-N-CA 123.519 0.728 . . . . 7.1799999999999997 112.519 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.22 -4.99 16.3 Favored 'Trans proline' 0 CA--C 1.573 2.467 0 C-N-CA 123.202 2.601 . . . . 6.0899999999999999 118.175 174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 160.16 10.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.266 1.21 . . . . 4.3700000000000001 114.266 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.19 103.59 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.921 -0.77 . . . . 3.8900000000000001 108.921 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.88 116.85 32.68 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.233 -1.025 . . . . 4.3499999999999996 108.233 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.6 mt -66.13 138.07 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 2.79 108.928 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.6 m -103.43 -72.05 0.71 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.907 -0.775 . . . . 4.21 108.907 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.76 151.31 50.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.136 0.574 . . . . 6.0999999999999996 110.801 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.2 tt -106.87 110.53 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.842 1.257 . . . . 5.0300000000000002 108.061 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.28 132.98 32.43 Favored Pre-proline 0 CA--C 1.578 2.057 0 CA-C-O 117.608 -1.187 . . . . 4.29 108.149 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.87 147.64 14.03 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 124.238 3.292 . . . . 4.54 117.524 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.56 -167.81 36.44 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.3 -0.864 . . . . 3.1800000000000002 114.071 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.49 -53.98 4.79 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-O 118.396 -1.224 . . . . 3.6600000000000001 115.867 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 175.95 -43.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 118.987 1.393 . . . . 3.6899999999999999 111.278 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.14 -37.57 87.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.936 2.198 . . . . 3.3700000000000001 116.936 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.8 32.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.133 2.642 . . . . 4.8499999999999996 118.133 163.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -75.22 -49.0 20.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.493 1.117 . . . . 6.6500000000000004 112.332 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -48.45 43.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.829 0.852 . . . . 4.9000000000000004 113.186 166.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.62 42.93 99.84 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.665 1.426 . . . . 5.2999999999999998 116.665 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -144.07 -35.34 0.36 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.099 0.96 . . . . 6.7400000000000002 112.571 -172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -45.18 126.65 6.33 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.632 1.716 . . . . 4.4500000000000002 115.632 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.01 135.29 34.07 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.702 1.239 . . . . 7.6900000000000004 109.335 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.46 159.19 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.527 0 CA-C-N 114.35 -1.295 . . . . 4.6799999999999997 112.172 166.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . 0.264 57.2 t30 60.79 34.06 19.91 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.164 1.542 . . . . 5.3600000000000003 115.164 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.19 119.12 38.27 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.332 -0.855 . . . . 3.73 108.899 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -78.8 102.33 8.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.781 -0.645 . . . . 3.6800000000000002 110.286 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.96 122.53 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.001 -1.111 . . . . 2.7599999999999998 108.001 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD12 ' SD ' ' A' ' 88' ' ' MET . 33.7 mt -116.85 -11.42 10.88 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.702 1.741 . . . . 2.77 115.702 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.92 73.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 122.207 2.276 . . . . 3.27 109.412 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.61 111.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.307 -0.871 . . . . 3.04 108.81 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 1.8 t30 66.57 -144.17 0.16 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.766 0.826 . . . . 4.8099999999999996 111.879 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -94.68 59.5 2.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.976 0.807 . . . . 5.5899999999999999 110.658 167.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.05 117.07 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.786 -2.672 . . . . 4.3200000000000003 103.786 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.88 105.88 2.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.205 1.002 . . . . 3.9700000000000002 110.942 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.0 t -116.7 123.49 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.576 -1.268 . . . . 2.54 107.576 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -179.15 -49.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.828 1.251 . . . . 4.3200000000000003 110.094 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -119.02 37.19 4.19 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 125.413 1.485 . . . . 6.0 111.371 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.06 143.05 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 105.959 -1.867 . . . . 4.7199999999999998 105.959 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -68.31 171.5 7.13 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.915 1.08 . . . . 5.29 113.915 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -47.51 -36.94 11.07 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.535 -1.697 . . . . 5.9900000000000002 114.142 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -54.12 -41.58 68.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 121.319 1.872 . . . . 5.8700000000000001 115.92 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.28 -29.57 70.35 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 117.608 2.447 . . . . 4.6200000000000001 117.608 164.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.59 -50.26 26.64 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 117.297 -1.335 . . . . 3.48 113.319 164.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 t -53.0 -43.73 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 C-N-CA 126.394 1.878 . . . . 3.7999999999999998 113.341 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -68.08 -43.76 77.8 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.374 1.25 . . . . 5.7999999999999998 114.374 167.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.31 79.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 117.018 2.229 . . . . 4.1900000000000004 117.018 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.49 -38.71 65.28 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.714 1.376 . . . . 3.5899999999999999 114.714 167.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -69.19 -48.68 61.47 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.286 1.217 . . . . 6.8399999999999999 114.286 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.67 -38.37 75.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.266 1.58 . . . . 7.2199999999999998 115.266 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.21 -50.75 15.42 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.762 1.764 . . . . 5.5700000000000003 115.762 160.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.34 -121.01 5.99 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 109.88 -1.288 . . . . 5.9400000000000004 109.88 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -76.76 13.33 1.04 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.998 2.222 . . . . 6.7800000000000002 116.998 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -145.8 79.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.993 -1.484 . . . . 5.6699999999999999 106.993 -172.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.81 98.81 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 4.5300000000000002 106.311 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.57 106.69 14.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.17 0.588 . . . . 7.1500000000000004 110.91 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.43 118.14 32.33 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.293 -1.003 . . . . 2.6099999999999999 108.293 -172.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.09 85.27 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.839 0.828 . . . . 4.5499999999999998 109.034 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -92.83 96.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 105.812 -1.921 . . . . 3.6400000000000001 105.812 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.488 ' SD ' HD12 ' A' ' 57' ' ' LEU . 47.6 mtp -61.22 115.3 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.862 -0.524 . . . . 4.8399999999999999 109.863 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 123.79 18.08 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 117.888 -1.053 . . . . 7.9900000000000002 110.876 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -43.71 125.97 4.36 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.57 1.692 . . . . 8.5199999999999996 115.57 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -148.5 -63.97 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 CA-C-O 115.496 -2.193 . . . . 10.800000000000001 108.695 -164.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.66 124.07 15.38 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 123.879 3.053 . . . . 9.6899999999999995 114.407 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--N 1.369 1.609 0 C-N-CA 123.452 2.768 . . . . 11.99 117.419 -178.004 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.343 -0.244 . . . . 7.11 110.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -126.28 128.02 46.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.317 -1.364 . . . . 5.18 107.317 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -116.14 88.74 2.95 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.998 -1.482 . . . . 5.74 106.998 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.52 115.81 16.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.062 0.545 . . . . 5.47 109.911 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.7 mt -112.1 92.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 104.935 -2.246 . . . . 3.87 104.935 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.2 m -77.93 107.21 10.3 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.184 0.992 . . . . 5.15 108.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD12 HD21 ' A' ' 85' ' ' LEU . 3.4 mt -108.62 175.56 5.42 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 113.662 -1.608 . . . . 4.27 107.719 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.86 179.64 4.17 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 122.754 1.264 . . . . 6.66 111.097 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.51 -46.35 88.83 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 116.955 -1.498 . . . . 8.76 113.29 163.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.54 -89.21 0.36 Allowed Glycine 0 CA--C 1.544 1.867 0 CA-C-N 119.346 0.976 . . . . 7.51 113.876 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.78 161.53 23.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.944 1.298 . . . . 8.74 108.779 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.314 1.3 t 70.21 -139.58 0.06 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.58 -1.325 . . . . 5.92 112.69 169.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.62 -96.89 0.09 OUTLIER Glycine 0 N--CA 1.482 1.707 0 CA-C-N 119.509 1.049 . . . . 4.78 112.28 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.048 HD12 HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -121.55 -72.19 0.7 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.35 -0.833 . . . . 4.21 109.198 176.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.88 -63.05 0.39 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 109.726 -1.35 . . . . 1.95 109.726 -164.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CE2' HD13 ' A' ' 50' ' ' LEU . 4.8 p90 -90.22 146.86 23.93 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.249 1.02 . . . . 2.5 112.404 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.19 125.1 28.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.295 -1.321 . . . . 2.49 109.281 167.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 pt -101.89 149.98 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.346 1.058 . . . . 2.98 109.875 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.41 124.0 37.09 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.75 -1.114 . . . . 3.76 109.797 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.63 168.48 54.8 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 122.005 0.78 . . . . 4.65 113.489 165.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 31' ' ' PRO . . . -143.14 -61.77 0.02 OUTLIER Glycine 0 CA--C 1.536 1.395 0 CA-C-N 114.368 -0.916 . . . . 5.31 113.899 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -61.53 -24.79 66.86 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.287 1.958 . . . . 5.94 116.287 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -123.65 -53.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.966 1.306 . . . . 6.75 110.681 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -116.58 88.36 24.18 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.217 -1.373 . . . . 6.7 108.92 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.31 90.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.756 2.971 . . . . 7.02 115.441 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -42.7 77.92 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.177 -0.919 . . . . 5.79 113.057 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.3 mm -92.08 146.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 108.516 -0.92 . . . . 6.26 108.516 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.31 76.22 0.44 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-N 115.588 -0.733 . . . . 7.38 112.402 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.97 -62.24 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 118.836 -0.602 . . . . 7.86 110.71 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.81 164.11 29.49 Favored Pre-proline 0 CA--C 1.572 1.802 0 C-N-CA 123.519 0.728 . . . . 7.18 112.519 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.431 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 63.2 Cg_endo -74.22 -4.99 16.3 Favored 'Trans proline' 0 CA--C 1.573 2.467 0 C-N-CA 123.202 2.601 . . . . 5.53 118.175 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 160.16 10.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.266 1.21 . . . . 4.0 114.266 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.674 HD11 ' O ' ' A' ' 67' ' ' VAL . 21.8 mm -100.19 103.59 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.921 -0.77 . . . . 3.4 108.921 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.88 116.85 32.68 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.233 -1.025 . . . . 3.85 108.233 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.429 HD13 HD21 ' A' ' 50' ' ' LEU . 9.6 mt -66.13 138.07 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 2.79 108.928 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.6 m -103.43 -72.05 0.71 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.907 -0.775 . . . . 3.72 108.907 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.76 151.31 50.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.136 0.574 . . . . 5.77 110.801 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.425 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 13.2 tt -106.87 110.53 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.842 1.257 . . . . 4.64 108.061 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.28 132.98 32.43 Favored Pre-proline 0 CA--C 1.578 2.057 0 CA-C-O 117.608 -1.187 . . . . 3.95 108.149 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.87 147.64 14.03 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 124.238 3.292 . . . . 3.95 117.524 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.56 -167.81 36.44 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.3 -0.864 . . . . 2.97 114.071 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.49 -53.98 4.79 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-O 118.396 -1.224 . . . . 3.66 115.867 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . 175.95 -43.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 118.987 1.393 . . . . 3.4 111.278 -172.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 38' ' ' ILE . . . -65.14 -37.57 87.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.936 2.198 . . . . 3.37 116.936 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.8 32.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.133 2.642 . . . . 4.85 118.133 163.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -75.22 -49.0 20.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.493 1.117 . . . . 6.08 112.332 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -48.45 43.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.829 0.852 . . . . 4.76 113.186 166.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.62 42.93 99.84 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.665 1.426 . . . . 5.3 116.665 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -144.07 -35.34 0.36 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.099 0.96 . . . . 6.39 112.571 -172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.626 HD13 ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -45.18 126.65 6.33 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.632 1.716 . . . . 4.14 115.632 -178.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.01 135.29 34.07 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.702 1.239 . . . . 7.15 109.335 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.46 159.19 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.527 0 CA-C-N 114.35 -1.295 . . . . 4.32 112.172 166.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . 0.264 57.2 t30 60.79 34.06 19.91 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.164 1.542 . . . . 5.07 115.164 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.19 119.12 38.27 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.332 -0.855 . . . . 3.73 108.899 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -78.8 102.33 8.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.781 -0.645 . . . . 3.32 110.286 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG21 HG13 ' A' ' 59' ' ' VAL . 33.7 mt -63.96 122.53 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.001 -1.111 . . . . 2.2 108.001 174.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD12 ' SD ' ' A' ' 88' ' ' MET . 33.7 mt -116.85 -11.42 10.88 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.702 1.741 . . . . 2.11 115.702 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.92 73.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 122.207 2.276 . . . . 2.67 109.412 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.597 HG22 HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -69.61 111.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.307 -0.871 . . . . 3.04 108.81 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 1.8 t30 66.57 -144.17 0.16 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.766 0.826 . . . . 4.59 111.879 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -94.68 59.5 2.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.976 0.807 . . . . 5.59 110.658 167.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.05 117.07 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.786 -2.672 . . . . 3.95 103.786 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.88 105.88 2.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.205 1.002 . . . . 3.97 110.942 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.597 HG21 HG22 ' A' ' 59' ' ' VAL . 74.0 t -116.7 123.49 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.576 -1.268 . . . . 2.22 107.576 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -179.15 -49.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.828 1.251 . . . . 3.77 110.094 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -119.02 37.19 4.19 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 125.413 1.485 . . . . 6.0 111.371 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.674 ' O ' HD11 ' A' ' 33' ' ' ILE . 27.7 m -128.06 143.05 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 105.959 -1.867 . . . . 4.35 105.959 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -68.31 171.5 7.13 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.915 1.08 . . . . 5.22 113.915 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -47.51 -36.94 11.07 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.535 -1.697 . . . . 5.31 114.142 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -54.12 -41.58 68.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 121.319 1.872 . . . . 5.81 115.92 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . . . -65.28 -29.57 70.35 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 117.608 2.447 . . . . 4.38 117.608 164.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.59 -50.26 26.64 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 117.297 -1.335 . . . . 3.32 113.319 164.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 t -53.0 -43.73 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 C-N-CA 126.394 1.878 . . . . 3.57 113.341 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 20.6 pt-20 -68.08 -43.76 77.8 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.374 1.25 . . . . 5.8 114.374 167.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.31 79.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 117.018 2.229 . . . . 3.86 117.018 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 14' ' ' LEU . 3.7 pp -73.49 -38.71 65.28 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.714 1.376 . . . . 3.59 114.714 167.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -69.19 -48.68 61.47 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.286 1.217 . . . . 6.43 114.286 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.67 -38.37 75.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.266 1.58 . . . . 7.22 115.266 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 82' ' ' ILE . . . -46.21 -50.75 15.42 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.762 1.764 . . . . 5.57 115.762 160.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.34 -121.01 5.99 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 109.88 -1.288 . . . . 5.67 109.88 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -76.76 13.33 1.04 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.998 2.222 . . . . 6.48 116.998 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.543 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -145.8 79.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.993 -1.484 . . . . 5.26 106.993 -172.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.81 98.81 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 4.26 106.311 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.57 106.69 14.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.17 0.588 . . . . 6.7 110.91 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -96.43 118.14 32.33 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.293 -1.003 . . . . 2.52 108.293 -172.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.09 85.27 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.839 0.828 . . . . 4.32 109.034 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -92.83 96.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 105.812 -1.921 . . . . 3.2 105.812 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.429 ' SD ' HD12 ' A' ' 57' ' ' LEU . 47.6 mtp -61.22 115.3 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.862 -0.524 . . . . 4.44 109.863 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 123.79 18.08 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 117.888 -1.053 . . . . 7.55 110.876 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -43.71 125.97 4.36 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.57 1.692 . . . . 8.05 115.57 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -148.5 -63.97 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 CA-C-O 115.496 -2.193 . . . . 10.33 108.695 -164.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.66 124.07 15.38 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 123.879 3.053 . . . . 9.33 114.407 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--N 1.369 1.609 0 C-N-CA 123.452 2.768 . . . . 11.45 117.419 -178.004 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.343 -0.244 . . . . 7.11 110.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -126.28 128.02 46.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.317 -1.364 . . . . 5.18 107.317 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -116.14 88.74 2.95 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.998 -1.482 . . . . 5.74 106.998 172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -76.52 115.81 16.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.062 0.545 . . . . 5.47 109.911 169.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.7 mt -112.1 92.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 104.935 -2.246 . . . . 3.87 104.935 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.2 m -77.93 107.21 10.3 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 122.184 0.992 . . . . 5.15 108.335 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD12 HD21 ' A' ' 85' ' ' LEU . 3.4 mt -108.62 175.56 5.42 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-N 113.662 -1.608 . . . . 4.27 107.719 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.86 179.64 4.17 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 122.754 1.264 . . . . 6.66 111.097 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.51 -46.35 88.83 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 116.955 -1.498 . . . . 8.76 113.29 163.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.54 -89.21 0.36 Allowed Glycine 0 CA--C 1.544 1.867 0 CA-C-N 119.346 0.976 . . . . 7.51 113.876 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -163.78 161.53 23.34 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.944 1.298 . . . . 8.74 108.779 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . 0.314 1.3 t 70.21 -139.58 0.06 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.58 -1.325 . . . . 5.92 112.69 169.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.62 -96.89 0.09 OUTLIER Glycine 0 N--CA 1.482 1.707 0 CA-C-N 119.509 1.049 . . . . 4.78 112.28 173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.048 HD12 HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -121.55 -72.19 0.7 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.35 -0.833 . . . . 4.21 109.198 176.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.88 -63.05 0.39 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 109.726 -1.35 . . . . 1.95 109.726 -164.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CE2' HD13 ' A' ' 50' ' ' LEU . 4.8 p90 -90.22 146.86 23.93 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.249 1.02 . . . . 2.5 112.404 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.19 125.1 28.87 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.295 -1.321 . . . . 2.49 109.281 167.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.2 pt -101.89 149.98 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 124.346 1.058 . . . . 2.98 109.875 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.41 124.0 37.09 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.75 -1.114 . . . . 3.76 109.797 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.63 168.48 54.8 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 122.005 0.78 . . . . 4.65 113.489 165.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 31' ' ' PRO . . . -143.14 -61.77 0.02 OUTLIER Glycine 0 CA--C 1.536 1.395 0 CA-C-N 114.368 -0.916 . . . . 5.31 113.899 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 m -61.53 -24.79 66.86 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 116.287 1.958 . . . . 5.94 116.287 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -123.65 -53.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.966 1.306 . . . . 6.75 110.681 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -116.58 88.36 24.18 Favored Pre-proline 0 CA--C 1.563 1.479 0 CA-C-O 117.217 -1.373 . . . . 6.7 108.92 177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.31 90.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.756 2.971 . . . . 7.02 115.441 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.57 -42.7 77.92 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.177 -0.919 . . . . 5.79 113.057 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.3 mm -92.08 146.83 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 N-CA-C 108.516 -0.92 . . . . 6.26 108.516 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.31 76.22 0.44 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-N 115.588 -0.733 . . . . 7.38 112.402 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.97 -62.24 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 118.836 -0.602 . . . . 7.86 110.71 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.81 164.11 29.49 Favored Pre-proline 0 CA--C 1.572 1.802 0 C-N-CA 123.519 0.728 . . . . 7.18 112.519 -170.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.431 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 63.2 Cg_endo -74.22 -4.99 16.3 Favored 'Trans proline' 0 CA--C 1.573 2.467 0 C-N-CA 123.202 2.601 . . . . 5.53 118.175 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -60.96 160.16 10.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.266 1.21 . . . . 4.0 114.266 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.674 HD11 ' O ' ' A' ' 67' ' ' VAL . 21.8 mm -100.19 103.59 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.921 -0.77 . . . . 3.4 108.921 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -104.88 116.85 32.68 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.233 -1.025 . . . . 3.85 108.233 -172.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.429 HD13 HD21 ' A' ' 50' ' ' LEU . 9.6 mt -66.13 138.07 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.432 -0.793 . . . . 2.79 108.928 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.6 m -103.43 -72.05 0.71 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.907 -0.775 . . . . 3.72 108.907 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.76 151.31 50.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.136 0.574 . . . . 5.77 110.801 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.425 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 13.2 tt -106.87 110.53 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.842 1.257 . . . . 4.64 108.061 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.28 132.98 32.43 Favored Pre-proline 0 CA--C 1.578 2.057 0 CA-C-O 117.608 -1.187 . . . . 3.95 108.149 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -49.87 147.64 14.03 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 124.238 3.292 . . . . 3.95 117.524 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.56 -167.81 36.44 Favored Glycine 0 CA--C 1.542 1.754 0 CA-C-N 115.3 -0.864 . . . . 2.97 114.071 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.49 -53.98 4.79 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-O 118.396 -1.224 . . . . 3.66 115.867 177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . 175.95 -43.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 118.987 1.393 . . . . 3.4 111.278 -172.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 38' ' ' ILE . . . -65.14 -37.57 87.83 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.936 2.198 . . . . 3.37 116.936 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.98 -10.8 32.18 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 118.133 2.642 . . . . 4.85 118.133 163.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -75.22 -49.0 20.77 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.493 1.117 . . . . 6.08 112.332 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -48.45 43.82 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.829 0.852 . . . . 4.76 113.186 166.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.62 42.93 99.84 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 116.665 1.426 . . . . 5.3 116.665 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -144.07 -35.34 0.36 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.099 0.96 . . . . 6.39 112.571 -172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.626 HD13 ' CE2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -45.18 126.65 6.33 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.632 1.716 . . . . 4.14 115.632 -178.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -92.01 135.29 34.07 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.702 1.239 . . . . 7.15 109.335 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -61.46 159.19 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.527 0 CA-C-N 114.35 -1.295 . . . . 4.32 112.172 166.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . 0.264 57.2 t30 60.79 34.06 19.91 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.164 1.542 . . . . 5.07 115.164 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.19 119.12 38.27 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.332 -0.855 . . . . 3.73 108.899 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.1 t -78.8 102.33 8.09 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.781 -0.645 . . . . 3.32 110.286 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG21 HG13 ' A' ' 59' ' ' VAL . 33.7 mt -63.96 122.53 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.001 -1.111 . . . . 2.2 108.001 174.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD12 ' SD ' ' A' ' 88' ' ' MET . 33.7 mt -116.85 -11.42 10.88 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 115.702 1.741 . . . . 2.11 115.702 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.92 73.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 122.207 2.276 . . . . 2.67 109.412 177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.597 HG22 HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -69.61 111.75 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.307 -0.871 . . . . 3.04 108.81 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 1.8 t30 66.57 -144.17 0.16 Allowed 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.766 0.826 . . . . 4.59 111.879 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -94.68 59.5 2.44 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.976 0.807 . . . . 5.59 110.658 167.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.05 117.07 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.786 -2.672 . . . . 3.95 103.786 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -67.88 105.88 2.12 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.205 1.002 . . . . 3.97 110.942 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.597 HG21 HG22 ' A' ' 59' ' ' VAL . 74.0 t -116.7 123.49 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.576 -1.268 . . . . 2.22 107.576 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -179.15 -49.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 124.828 1.251 . . . . 3.77 110.094 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -119.02 37.19 4.19 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 125.413 1.485 . . . . 6.0 111.371 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.674 ' O ' HD11 ' A' ' 33' ' ' ILE . 27.7 m -128.06 143.05 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 N-CA-C 105.959 -1.867 . . . . 4.35 105.959 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -68.31 171.5 7.13 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.915 1.08 . . . . 5.22 113.915 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -47.51 -36.94 11.07 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.535 -1.697 . . . . 5.31 114.142 165.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -54.12 -41.58 68.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 121.319 1.872 . . . . 5.81 115.92 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 74' ' ' GLU . . . -65.28 -29.57 70.35 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 117.608 2.447 . . . . 4.38 117.608 164.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.59 -50.26 26.64 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 117.297 -1.335 . . . . 3.32 113.319 164.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 t -53.0 -43.73 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 C-N-CA 126.394 1.878 . . . . 3.57 113.341 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 20.6 pt-20 -68.08 -43.76 77.8 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 114.374 1.25 . . . . 5.8 114.374 167.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.31 79.84 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 117.018 2.229 . . . . 3.86 117.018 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.048 HD22 HD12 ' A' ' 14' ' ' LEU . 3.7 pp -73.49 -38.71 65.28 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.714 1.376 . . . . 3.59 114.714 167.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -69.19 -48.68 61.47 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.286 1.217 . . . . 6.43 114.286 173.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -57.67 -38.37 75.03 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.266 1.58 . . . . 7.22 115.266 169.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 82' ' ' ILE . . . -46.21 -50.75 15.42 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.762 1.764 . . . . 5.57 115.762 160.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.34 -121.01 5.99 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 109.88 -1.288 . . . . 5.67 109.88 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.7 m -76.76 13.33 1.04 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.998 2.222 . . . . 6.48 116.998 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.543 ' O ' ' HB1' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -145.8 79.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.993 -1.484 . . . . 5.26 106.993 -172.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.81 98.81 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 4.26 106.311 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -113.57 106.69 14.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.17 0.588 . . . . 6.7 110.91 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -96.43 118.14 32.33 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.293 -1.003 . . . . 2.52 108.293 -172.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -86.09 85.27 7.36 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.839 0.828 . . . . 4.32 109.034 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -92.83 96.13 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 105.812 -1.921 . . . . 3.2 105.812 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.429 ' SD ' HD12 ' A' ' 57' ' ' LEU . 47.6 mtp -61.22 115.3 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.862 -0.524 . . . . 4.44 109.863 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.77 123.79 18.08 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 117.888 -1.053 . . . . 7.55 110.876 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -43.71 125.97 4.36 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.57 1.692 . . . . 8.05 115.57 -169.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -148.5 -63.97 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 CA-C-O 115.496 -2.193 . . . . 10.33 108.695 -164.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.66 124.07 15.38 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 C-N-CA 123.879 3.053 . . . . 9.33 114.407 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--N 1.369 1.609 0 C-N-CA 123.452 2.768 . . . . 11.45 117.419 -178.004 . . . . . . . . 0 0 . 1 stop_ save_